Interact to see
Advertisement
Advertisement
ADNRX vs VMGIX
ADNRX vs VMGIX Comparison
Open Charts ADNRX vs VMGIX
American Beacon ARK Transfmt Innov R6
Price$19.51
Change+$0.39 (+2.04%)
VolumeN/A
Net Assets201.11M
Vanguard Mid-Cap Growth Index Investor
Price$110.06
Change+$0.84 (+0.77%)
VolumeN/A
Net Assets29.66B
ADNRX vs VMGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. VMGIX commentary
Jun 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and VMGIX is a StrongBuy.
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 29.7B vs. ADNRX (201M). VMGIX pays higher dividends than ADNRX: VMGIX (0.54) vs ADNRX (0.00). ADNRX was incepted earlier than VMGIX: ADNRX (5 years) vs VMGIX (19 years). ADNRX (1.13) is less costly to investors than VMGIX (0.19). ADNRX is a more actively managed with annual turnover of: 38.00 vs. VMGIX (21.00). ADNRX has a lower initial minimum investment than VMGIX: ADNRX (0) vs VMGIX (3000). ADNRX annual gain was more profitable for investors over the last year : 63.13 vs. VMGIX (21.17).
| ADNRX | VMGIX | ADNRX / VMGIX | |
| Total Expense Ratio | 1.00 | 0.19 | 526% |
| Annual Report Gross Expense Ratio | 1.13 | 0.19 | 595% |
| Fund Existence | 5 years | 19 years | - |
| Gain YTD | 25.144 | 9.431 | 267% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 201M | 29.7B | 1% |
| Annual Yield % from dividends | 0.00 | 0.54 | - |
| Returns for 1 year | 63.13 | 21.17 | 298% |
| Returns for 3 years | 47.47 | 52.26 | 91% |
| Returns for 5 years | N/A | 73.05 | - |
| Returns for 10 years | N/A | 165.83 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement